Phi Therapeutics (California) Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 14

Phi Therapeutics (California) General Information

Description

Operator of a skincare product platform intended to treat acne. The company utilizes microbiome and bacteriophage technology to target acne-causing bacteria while preserving beneficial skin microbiota, enabling customers to access acne treatment without disrupting skin health.

Contact Information

Website
www.phyla.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1250 Petaluma Boulevard North
  • Petaluma, CA 94952
  • United States
+1 (707)
Primary Industry
Personal Products
Other Industries
Biotechnology
Corporate Office
  • 1250 Petaluma Boulevard North
  • Petaluma, CA 94952
  • United States
+1 (707)

Phi Therapeutics (California) Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phi Therapeutics (California) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC (Series A) 26-Jun-2024 Completed Generating Revenue
5. Later Stage VC 07-Dec-2023 Completed Generating Revenue
4. Accelerator/Incubator 12-Jan-2021 Completed Generating Revenue
3. Seed Round 04-Jun-2019 Completed Generating Revenue
2. Grant 05-Sep-2015 $165K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Phi Therapeutics (California)’s complete valuation and funding history, request access »

Phi Therapeutics (California) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Series A 2,556,028 $0.001000 8% $1.96 $1.96 1x $1.96 9.28%
Seed 1,805,773 $0.001000 8% $0.87 $0.87 1x $0.87 21.86%
To view Phi Therapeutics (California)’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Phi Therapeutics (California) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a skincare product platform intended to treat acne. The company utilizes microbiome and bacteriophage techno
Personal Products
Petaluma, CA
10 As of 2022

San Diego, CA
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phi Therapeutics (California) Competitors (9)

One of Phi Therapeutics (California)’s 9 competitors is Dermala, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dermala Venture Capital-Backed San Diego, CA
Oskia Skincare Corporation London, United Kingdom
AHAVA Formerly PE-Backed Airport City, Israel
It Cosmetics Formerly PE-Backed Westfield, NJ
La Roche Posay Formerly PE-Backed La Roche-Posay, France
You’re viewing 5 of 9 competitors. Get the full list »

Phi Therapeutics (California) Patents

Phi Therapeutics (California) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024252638-A1 Compositions and methods for the treatment of skin diseases and conditions including eczema Pending 03-Apr-2023
EP-4687933-A2 Compositions and methods for the treatment of skin diseases and conditions including eczema Pending 03-Apr-2023
US-12605416-B2 Compositions and methods for the treatment of skin diseases and conditions including eczema Active 03-Apr-2023
US-20250134940-A1 Compositions and methods for the treatment of skin diseases and conditions including eczema Active 03-Apr-2023
US-20260335384-A1 Compositions and methods for the treatment of skin diseases and conditions including eczema Pending 03-Apr-2023 A61K35/76
To view Phi Therapeutics (California)’s complete patent history, request access »

Phi Therapeutics (California) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phi Therapeutics (California) Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Lift Ventures Accelerator/Incubator Minority
Maximum Effort Corporation Minority
N Plus One Ventures Venture Capital Minority
Squared Circles VC-Backed Company Minority
You’re viewing 5 of 14 investors. Get the full list »

Phi Therapeutics (California) FAQs

  • When was Phi Therapeutics (California) founded?

    Phi Therapeutics (California) was founded in 2014.

  • Where is Phi Therapeutics (California) headquartered?

    Phi Therapeutics (California) is headquartered in Petaluma, CA.

  • What is the size of Phi Therapeutics (California)?

    Phi Therapeutics (California) has 10 total employees.

  • What industry is Phi Therapeutics (California) in?

    Phi Therapeutics (California)’s primary industry is Personal Products.

  • Is Phi Therapeutics (California) a private or public company?

    Phi Therapeutics (California) is a Private company.

  • What is Phi Therapeutics (California)’s current revenue?

    The current revenue for Phi Therapeutics (California) is .

  • How much funding has Phi Therapeutics (California) raised over time?

    Phi Therapeutics (California) has raised $9.2M.

  • Who are Phi Therapeutics (California)’s investors?

    , Lift Ventures, Maximum Effort, N Plus One Ventures, and Squared Circles are 5 of 14 investors who have invested in Phi Therapeutics (California).

  • Who are Phi Therapeutics (California)’s competitors?

    Dermala, Oskia Skincare, AHAVA, It Cosmetics, and La Roche Posay are some of the 9 competitors of Phi Therapeutics (California).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process